MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-021-98538-z

Медицинская библиотека · Scientific reports · 2021

Immunomodulatory effects of thalidomide in an experimental brain death liver donor model.

Santana Alexandre Chagas, Andraus Wellington, Silva Filipe Miranda Oliveira, Dellê Humberto, Pepineli Rafael, de Moraes Edvaldo Leal, Scavone Cristoforo, de Sá Lima Larissa, Degaspari Sabrina, Brasil Sergio, Solla Davi Jorge Fontoura, Ruiz Liliane Moreira, de Oliveira-Braga Karina Andrighetti, Nepomuceno Natalia Aparecida, Pêgo-Fernandes Paulo Manuel, Tullius Stefan Gunther, Figueiredo Eberval Gadelha

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Brain death is characterized by a generalized inflammatory response that results in multiorgan damage. This process is mainly mediated through cytokines, which amplify graft immunogenicity. We investigated the immunological response in a brain death liver donor model and analysed the effects of thalidomide, a drug with powerful immunomodulatory properties. Brain death was induced in male Lewis rats. We studied three groups: Control (sham-operated rats in which trepanation was performed without inserting the balloon catheter), BD (rats subjected to brain death by increasing intracranial pressure) and BD + Thalid (BD rats receiving thalidomide after brain death). After 6 h, serum levels of AST, ALT, LDH, and ALP as well as systemic and hepatic levels of TNF-α, IL1-β, IL-6, and IL-10 were analysed. We also determined the mRNA expression of MHC Class I and Class II, NF-κB, and macrophage infiltration. NF-κB was also examined by electrophoretic mobility shift assay. Thalidomide treatment significantly reduced serum levels of hepatic enzymes and TNF-α, IL-1-β, and IL-6. These cytokines were evaluated at either the mRNA expression or protein level in liver tissue. In addition, thalidomide administration resulted in a significant reduction in macrophages, MHC Class I and Class II, and NF-κB activation. This study reveals that thalidomide significantly inhibited the immunologic response and graft immunogenicity, possibly through suppression of NF-κB activation.

Для цитирования: Santana Alexandre Chagas, Andraus Wellington, Silva Filipe Miranda Oliveira, Dellê Humberto, Pepineli Rafael, de Moraes Edvaldo Leal, Scavone Cristoforo, de Sá Lima Larissa, Degaspari Sabrina, Brasil Sergio, Solla Davi Jorge Fontoura, Ruiz Liliane Moreira, de Oliveira-Braga Karina Andrighetti, Nepomuceno Natalia Aparecida, Pêgo-Fernandes Paulo Manuel, Tullius Stefan Gunther, Figueiredo Eberval Gadelha. Immunomodulatory effects of thalidomide in an experimental brain death liver donor model.. Scientific reports. 2021. DOI: 10.1038/s41598-021-98538-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.